Aldevron specializes in advanced biomanufacturing technologies, particularly in the fields of cell and gene therapy, mRNA production, and CRISPR gene editing. The company offers a comprehensive range of services, including high-quality plasmid DNA manufacturing, mRNA custom manufacturing with lipid nanoparticle (LNP) encapsulation, and protein/enzyme production. Their innovative Nanoplasmid™ technology provides a next-generation backbone that enhances performance and safety in plasmid design. Aldevron's facilities are equipped to support the entire development process, from research and preclinical stages to clinical trials and commercial production, ensuring compliance with various quality standards such as GMP and ISO certifications.

In addition to their manufacturing capabilities, Aldevron provides a suite of gene editing tools, including high-fidelity CRISPR nucleases that are available in both research-grade and cGMP formats. Their proprietary Codex® HiCap RNA Polymerase is designed to streamline RNA manufacturing by reducing impurities and enhancing the safety of RNA therapeutics. Aldevron also offers Ribonucleoprotein (RNP) production services, which facilitate the transformation of CRISPR reagents into therapeutic applications. With a focus on innovation and regulatory compliance, Aldevron supports over 1,000 clients in advancing their scientific endeavors across various life science applications.

United States

Aldevron is proud to be part of Danaher. 

Aldevron is a leader in advancing biological science. Our custom development and manufacturing services have provided scientists around the world with the tools to make significant scientific advances. We provide high-quality plasmid DNA, proteins, enzymes, and other biologicals to help our partners achieve ground-breaking science.

Aldevron

Company Details